NCT06322342 2025-12-26
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Phase 2 Completed
Clinical Trials
26 trialsNCT07305285 2025-12-26
Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma
West China Hospital
Phase NA Completed
NCT04057976 2025-09-12
Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas
King's College Hospital NHS Trust
Phase NA Completed
NCT04743310 2025-06-13
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Cedars-Sinai Medical Center
Phase 2 Completed
NCT02249572 2025-04-02
V-REX
Haukeland University Hospital
Phase NA Completed
NCT04241679 2024-04-25
ANTS
Washington University School of Medicine
Phase NA Completed
NCT04351373 2023-08-01
Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
Mayo Clinic
Phase 2 Completed
NCT03581331 2023-07-14
SVorthoptie
Assistance Publique Hopitaux De Marseille
Phase NA Completed
NCT03958006 2023-04-20
Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma
Henry Ford Health System
Phase NA Completed
NCT04658836 2022-08-24
Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF
Medical University of Vienna
Phase 1 Completed
NCT04148534 2022-06-29
Compare the Operating Condition of Two Levels of Muscle Relaxation on Facial Nerve MEP Monitoring in CPA Surgery
Cairo University
Phase NA Completed
NCT02129647 2021-12-01
Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
NYU Langone Health
Phase 2 Completed
NCT02948790 2021-10-20
NeuriStim
Oticon Medical
Phase NA Completed
NCT01125046 2021-01-22
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas
Northwestern University
Phase 2 Completed
NCT00863122 2021-01-12
Concentration and Activity of Lapatinib in Vestibular Schwannomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT01880749 2020-05-13
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT02309099 2019-01-07
Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach
University of North Carolina, Chapel Hill
Phase NA Completed
NCT01207687 2018-08-27
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
National Cancer Institute (NCI)
Phase 2 Completed
NCT03638310 2018-08-20
Role of Psychiatric Profile in Prehabituated Patients After Vestibular Schwannoma Surgery
Charles University, Czech Republic
Phase NA Completed
NCT01490476 2017-05-23
AFINF2
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT02104323 2017-02-09
Endostatin
Beijing Tiantan Hospital
Phase 2 Completed
NCT02963896 2016-11-15
ITG
University Hospital, Motol
Phase NA Completed
NCT00973739 2016-03-22
Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
NYU Langone Health
Phase 2 Completed
NCT01119599 2015-09-29
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00411216 2015-08-07
Recovery of Visual Acuity in People With Vestibular Deficits
Emory University
Phase NA Completed
NCT00004437 2015-03-25
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Phase 2 Completed